Compounded Tirzepatide vs NAD+ Therapy
An honest, side-by-side look at two treatment options — so you and your provider can decide what may work best for you.
How Do They Compare?
All medications referenced on this page are compounded by a licensed 503A pharmacy and are not FDA-approved.
Side-by-Side Comparison
|
Compounded Tirzepatide
Available Now
|
NAD+ Therapy
Available Now
|
|
|---|---|---|
| Category | weight-management | vitamin |
| Description | Dual GIP/GLP-1 receptor agonist for weight management | Cellular energy and longevity support |
| Price | $285/mo If prescribed by a provider |
$285/mo If prescribed by a provider |
| Features |
|
|
| Considerations |
|
|
| Availability | Available Now | Available Now |
| Get Started | Get Started |
Compounded Tirzepatide
Available NowIf prescribed by a provider
Category
weight-management
Description
Dual GIP/GLP-1 receptor agonist for weight management
Features
- Targets two hormonal pathways (GIP and GLP-1)
- May help reduce appetite through dual mechanism
- Weekly subcutaneous injection
- Dosage gradually titrated under medical supervision
Considerations
- Compounded medications are not FDA-approved
- Common side effects may include nausea, diarrhea, and decreased appetite
- Not suitable for individuals with a history of MEN 2
- Requires ongoing provider monitoring
NAD+ Therapy
Available NowIf prescribed by a provider
Category
vitamin
Description
Cellular energy and longevity support
Features
- May support cellular energy production and repair
- May help improve mental clarity
- Plays a role in DNA repair mechanisms
- Available via injection or IV infusion
Considerations
- Research on NAD+ supplementation is still evolving
- Side effects may include flushing and nausea
- IV infusions require clinical administration
- Typically not covered by insurance
Frequently Asked Questions
Related Comparisons
NAD+ Therapy vs Lipo-MIC Injections
NAD+ Therapy vs Vitamin B12 Injections
NAD+ Therapy vs AOD-9604
NAD+ Therapy vs CJC-1295 / Ipamorelin
NAD+ Therapy vs PT-141 (Bremelanotide)
NAD+ Therapy vs BPC-157
Compounded tirzepatide is not FDA-approved. All treatments require evaluation and prescription by a licensed healthcare provider. Individual results may vary. This information is not intended to diagnose, treat, cure, or prevent any disease.
Ready to Explore Your Options?
Connect with a licensed provider who can help determine which treatment may be appropriate for your individual health goals.
Get StartedReady to get started?
Talk to a licensed provider